Gufic BioSciences Ltd (GUFICBIO) — Announcement | 28 September 2026 (2 announcements)

28 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Announcement🔴 High Importance Neutral📄 PDF

📢 Key Event

Gufic BioSciences receives Crisil ESG rating of 62 (Strong) for FY 2025-26

💡 Investor Takeaway

The ESG rating validates Gufic's sustainability efforts and may enhance its appeal to ESG-focused investors.

Gufic BioSciences announced that Crisil ESG Ratings assigned an overall ESG rating of CRISIL ESG 62 (Category: Strong) for FY 2025-26, reflecting strong sustainability performance. The rating was issued independently based on publicly available FY 2025-26 data and is now being formally communicated to exchanges.

2Announcement Neutral📄 PDF

📢 Key Event

Trading window closure announced for Gufic BioSciences

💡 Investor Takeaway

Shareholders must plan trades around the upcoming blackout period.

Gufic BioSciences announced that its trading window will close on October 1, 2026, and remain shut until 48 hours after the unaudited financial results for the quarter and half-year ended September 30, 2026 are declared. The board meeting to approve these results will be scheduled shortly.

📊 Stock Analysis — GUFICBIO ✨ Ask AI About This

About Gufic BioSciences Ltd (GUFICBIO)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,224.9 CrP/E: 57.5ROE: 11.1%ROCE: 12.9%Div Yield: 0.02%

View full GUFICBIO stock details →

📡 Get AI alerts when GUFICBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUFICBIO — Free

💡 Ask AI about this filing

"How does this ESG rating compare to peers in the chemical sector?""What specific criteria contributed to the Strong category rating?""Will this rating affect Gufic's access to green financing or insurance premiums?"

Ask AI Free →

📊 More GUFICBIO filings

🔴 Announcement — 29 September 2026Gufic BioSciences announced it received an appellate order from the Commissioner of Income Tax (Appe...
🔴 Announcement — 24 September 2026Gufic BioSciences disclosed penalties of ₹8,000 and [amount not verified] imposed by BSE and NSE for...
🔴 Announcement — 8 September 2026Gufic BioSciences announced that CRISIL reaffirmed its credit ratings on bank facilities, upgrading ...
🟡 Board Meeting — 4 September 2026Gufic Biosciences held its 42nd AGM on September 4, 2026 via video conference, approving the audited...
🟡 Board Meeting — 2 September 2026Gufic Biosciences announced on September 2, 2026 that Ms. Ami Shah was promoted to Head-Legal while ...

See all GUFICBIO filings →

🔥 Also filed on 28 September 2026

JSLJindal Stainless LtdCorporate Action GODREJPROPGodrej Properties LtdAnnouncement MANINFRAMan Infraconstruction LtdAnnouncement KPILKalpataru Projects International LtdAnnouncement SUNPHARMASun Pharmaceutical Industries LtdAnnouncement JUBLPHARMAJubilant Pharmova LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GUFICBIO files new disclosures

Track GUFICBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.